40.1K(top 0.1%)
papers
727.6K(top 0.1%)
citations
214(top 0.1%)
h-index
434(top 0.1%)
g-index
50.8K
all documents
828.9K
doc citations
17.6K
citing journals

Top Articles

#TitleJournalYearCitations
1Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet, The202036,800
2Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet, The20126,376
3Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy20164,701
4Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJAMA - Journal of the American Medical Association20203,876
5Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyLancet Oncology, The20113,758
6Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care20123,439
7Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep LearningCell20182,822
8Artificial intelligence in healthcare: past, present and futureStroke and Vascular Neurology20172,009
9Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateHepatology International20161,908
10Ferroptosis: past, present and futureCell Death and Disease20201,679
11Gender Differences in Patients With COVID-19: Focus on Severity and MortalityFrontiers in Public Health20201,609
12Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney DiseaseJournal of the American Society of Nephrology: JASN20061,580
13Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateHepatology International20171,537
14Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis20201,482
15Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin SystemCirculation Research20201,478
16Prevalence, Incidence, and Mortality of Stroke in ChinaCirculation20171,450
17Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1Autophagy20211,430
18Viral load of SARS-CoV-2 in clinical samplesLancet Infectious Diseases, The20201,385
19Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic AttackNew England Journal of Medicine20131,384
20Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodiesNature20221,350
21Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)Clinical Infectious Diseases20201,334
22A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2Nature20201,237
23Riociguat for the Treatment of Chronic Thromboembolic Pulmonary HypertensionNew England Journal of Medicine20131,144
24Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B CellsCell20201,139
25Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort studyEuropean Respiratory Journal20201,116
26Mental Health and Psychosocial Problems of Medical Health Workers during the COVID-19 Epidemic in ChinaPsychotherapy and Psychosomatics20201,108
27Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of PneumoniaClinical Chemistry20201,098
28Gut microbiota dysbiosis contributes to the development of hypertensionMicrobiome20171,086
29The practical implementation of artificial intelligence technologies in medicineNature Medicine20191,079
30Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19Nature Immunology20201,066
31Major Causes of Death among Men and Women in ChinaNew England Journal of Medicine20051,041
32The experiences of health-care providers during the COVID-19 crisis in China: a qualitative studyThe Lancet Global Health20201,039
33A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2Science2020964
34Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaHepatology International2010944
35Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional studyLancet, The2018938
36Identification of a novel coronavirus causing severe pneumonia in human: a descriptive studyChinese Medical Journal2020928
37Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia2020921
38Stroke in China: advances and challenges in epidemiology, prevention, and managementLancet Neurology, The2019903
39Characteristics of COVID-19 infection in BeijingJournal of Infection2020890
40BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infectionNature2022889
41Transfer of mitochondria from astrocytes to neurons after strokeNature2016872
42The Effects of Social Support on Sleep Quality of Medical Staff Treating Patients with Coronavirus Disease 2019 (COVID-19) in January and February 2020 in ChinaMedical Science Monitor2020860
43The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell functionBiomaterials2010854
44Binding of SARS coronavirus to its receptor damages islets and causes acute diabetesActa Diabetologica2010850
45Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkersJournal of Allergy and Clinical Immunology2016833
46Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 PatientsCell Host and Microbe2020811
47MERS, SARS and other coronaviruses as causes of pneumoniaRespirology2018795
48Intensive Blood-Pressure Lowering in Patients with Acute Cerebral HemorrhageNew England Journal of Medicine2016769
49Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)Hepatology International2009709
50Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trialLancet Oncology, The2014695